CoChat

Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse‐controlled release for obesity

Kang, J. G., Park, C.‐Y., Kang, J. H., Park, Y.‐W., Park, S. W. · 2010 · Diabetes, Obesity and Metabolism
Cited by 120

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Aim: To evaluate the efficacy and safety of a newly developed formulation of phentermine diffuse‐controlled release (DCR) in patients with obesity. Methods: This was a randomized, double‐blind, placebo‐controlled trial of 12 weeks of treatment with phentermine DCR 30 mg (n = 37) or placebo (n = 37), administered once daily in patients with obesity with controlled diabetes, hypertension or dyslipidaemia. The efficacy was evaluated by changes in body weight and waist circumference from baseline at 12 weeks and also changes in metabolic parameters, including lipid profiles and blood pressure. Results: The participants in the phentermine DCR group showed significant reductions in body weight (−8.1 ± 3.9 vs. −1.7 ± 2.9 kg, p < 0.001) and waist circumference (7.2 ± 0.5 vs. 2.1 ± 0.6 cm, p < 0.001) compared with those in the placebo group. Weight reductions of 5% or greater from the baseline (95.8 vs. 20.8%, p < 0.001) and 10% or more (62.5 vs. 4.7%, p < 0.001) were achieved in the DCR phentermine group and placebo group, respectively. Total cholesterol and low‐density lipoprotein cholesterol (LDL‐C) levels were significantly improved in the phentermine DCR group. However, there were no significant differences in systolic and diastolic blood pressure between the groups. Dry mouth and insomnia were the most common adverse events, but these were mild to moderate and transient. Conclusions: Short‐term phentermine DCR treatment resulted in significant reduction in weight and improvement of metabolic parameters, including waist circumference and some lipid profiles, without clinically severe adverse events. Further study is needed to show long‐term efficacy and safety of phentermine DCR in Korean patients with obesity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1463-1326.2010.01242.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 120

Metadata

Authors
Kang, J. G., Park, C. ‐., Kang, J. H., Park, Y. ‐., & Park, S. W.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2010-08-29
Volume
12
Issue
10
Pages
876-882
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W1988538525
Cited by
120
References
5
FWCI
4.71
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse‐controlled release for obesity. https://app.cochat.ai/papers/10.1111/j.1463-1326.2010.01242.x
The paper
Kang, J. G., Park, C. ‐., Kang, J. H., Park, Y. ‐., & Park, S. W. (2010). Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse‐controlled release for obesity. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/j.1463-1326.2010.01242.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.